Skip to main content

Whitehawk Therapeutics, Inc.

WHWK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001422142

No open-market purchases or sales by Whitehawk Therapeutics, Inc. insiders were filed in the last 90 days; 77 institutions reported holding it in 13F filings for Q2 2026, worth $198.0M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Whitehawk Therapeutics, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of WHWK: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders4243+1
Shares26.6M30.2M+3.64M (+13.7%)
Value$34.3M$51.0M+$16.8M (+48.9%)

New holders (12)

Institutions that held Whitehawk Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to WHWK in Q2 2021
InstitutionSharesValue% of portfolio
Avoro Capital Advisors LLC4,500,000$7.61M0.13%
Ra Capital Management, L.P.2,693,309$4.55M0.07%
Rock Springs Capital Management LP133,375$225.0K0.00%
State Street Corp127,850$216.0K0.00%
J. Goldman & Co LP94,500$160.0K0.01%
Atom Investors LP79,996$135.0K0.03%
Millennium Management LLC74,008$125.0K0.00%
XTX Topco Ltd17,331$29.0K0.01%
ExodusPoint Capital Management, LP15,017$25.0K0.00%
Lindbrook Capital, LLC5,000$8.00K0.00%
NEXT Financial Group, Inc1,500$3.00K0.00%
Heritage Wealth Management, LLC3––

Sold out (11)

Institutions that held Whitehawk Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of WHWK in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
EcoR1 Capital, LLC2,072,782$2.67M
Opaleye Management Inc.1,000,000$1.29M
Scion Asset Management, LLC1,000,000$1.29M
Keudell/Morrison Wealth Management30,694$40.0K
Squarepoint Ops LLC17,019$22.0K
Jane Street Group, LLC15,581$20.0K
Charles Schwab Investment Management Inc12,835$17.0K
Lakeview Capital Partners, LLC12,722$16.0K
Qube Research & Technologies Ltd12,016$16.0K
Barclays PLC11,648$15.0K
Tower Research Capital LLC (TRC)3,288$4.00K